Company: HCTI
Filing Date: 2025-05-09
Form Type: S-1/A
Source: 0001213900-25-041190
Chunk: 21

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-09
Form: S-1/A
Chunk 21
---
<div align='center'>8

USE OF PROCEEDS</div>

This prospectus relates to the Common Stock
that may be offered and sold from time to time by the selling stockholders. We are not selling any shares of our Common Stock in this
offering, and we will not receive any of the proceeds from the sale of shares of our Common Stock by the selling stockholder. The selling
stockholders will receive all of the proceeds from any sales of the shares of our Common Stock offered hereby, however we will receive
the proceeds from any cash exercises of the Purchase Warrants; however as a result of the zero exercise price option we do not expect
to receive any cash proceeds from the exercise of the Series B Warrants.

<div align='center'>9

DIVIDEND POLICY</div>

We have never declared or paid any cash dividend
and do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance
operations and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides
to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus,
general financial condition, contractual restrictions and other factors that our directors may deem relevant.

<div align='center'>THE PRIVATE PLACEMENT</div>

Background

On March 20, 2024 the Company received a notification
from Nasdaq that it did not comply with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth
in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Rule”) and was given until September 16, 2024 to comply
with this requirement and such deadline was subsequently extended by the Panel. On February 20, 2025 the Panel approved the Company’s
request for the Panel to consider it in compliance with the Stockholders’ Equity Rule, if by February 28, 2025, it disclosed in
a public filing that it believed it had regained compliance with the Stockholders’ Equity Rule and the event that occurred resulting
in such compliance. On February 28, 2025, the Company publicly disclosed in a Current Report on Form 8-K that it believed it was in compliance
with the Rule as a result of receiving net proceeds of approximately $13.68 million from the Private Placement (as defined below).

The purpose of the Private Placement was for
the Company